Avidity Partners Management LP
- SEC CIK
- 0001791827
- Latest filing
- Aug 14, 2026
Holdings in Q2 2025
Holdings as of Jun 30, 2025, filed Aug 14, 2025. Long positions only; changes compare share counts with Q1 2025.
- Positions
- 55
- −8 vs. Q1 2025
- Portfolio value
- $498.8M
- +$13.9M (+2.9%) vs. Q1 2025
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| CGONCG Oncology, Inc. | COM | 1,499,942 | $39.0M | 7.8% | +519,000+52.9% | Added | History |
| BSXBoston Scientific Corp | Stock | 321,800 | $34.6M | 6.9% | −14,200−4.2% | Reduced | History |
| NTRANatera, Inc. | COM | 199,300 | $33.7M | 6.8% | +80,100+67.2% | Added | History |
| DNTHDianthus Therapeutics, Inc. | COM | 1,742,902 | $32.5M | 6.5% | +22,000+1.3% | Added | History |
| EXASExact Sciences Corp | COM | 355,000 | $18.9M | 3.8% | +2,000+0.6% | Added | History |
| THCTenet Healthcare Corp | COM NEW | 106,000 | $18.7M | 3.7% | +34,000+47.2% | Added | History |
| DXCMDexcom Inc | COM | 210,500 | $18.4M | 3.7% | +30,500+16.9% | Added | History |
| DHRDanaher Corp | Stock | 89,700 | $17.7M | 3.6% | +45,200+101.6% | Added | History |
| HNGEHinge Health, Inc. | CL A | 322,344 | $16.7M | 3.3% | +322,344 | New | History |
| ISRGIntuitive Surgical Inc | COM NEW | 27,100 | $14.7M | 3.0% | +27,100 | New | History |
| GMABGenmab A/S | SPONSORED ADS | 650,000 | $13.4M | 2.7% | +650,000 | New | History |
| RGENRepligen Corp | COM | 106,500 | $13.2M | 2.7% | +106,500 | New | History |
| TMOThermo Fisher Scientific Inc. | Stock | 29,600 | $12.0M | 2.4% | +14,100+91.0% | Added | History |
| TEVATeva Pharmaceutical Industries Ltd | SPONSORED ADS | 689,500 | $11.6M | 2.3% | +208,500+43.3% | Added | History |
| JBIOJade Biosciences, Inc. | COM NEW | 1,127,186 | $11.3M | 2.3% | +1,127,186 | New | History |
| PHATPhathom Pharmaceuticals, Inc. | COM | 1,064,500 | $10.2M | 2.0% | +264,500+33.1% | Added | History |
| UNHUnitedHealth Group Inc | Stock | 32,000 | $9.98M | 2.0% | −18,500−36.6% | Reduced | History |
| MCKMcKesson Corp | Stock | 13,500 | $9.89M | 2.0% | +13,500 | New | History |
| AXSMAxsome Therapeutics, Inc. | COM | 94,500 | $9.86M | 2.0% | +17,500+22.7% | Added | History |
| CORCencora, Inc. | Stock | 32,800 | $9.84M | 2.0% | −6,500−16.5% | Reduced | History |
| HQYHealthequity, Inc. | COM | 92,000 | $9.64M | 1.9% | +14,000+17.9% | Added | History |
| EHCEncompass Health Corp | COM | 74,000 | $9.07M | 1.8% | +74,000 | New | History |
| RVMDRevolution Medicines, Inc. | COM | 228,600 | $8.41M | 1.7% | +15,600+7.3% | Added | History |
| AKROAkero Therapeutics, Inc. | COM | 134,000 | $7.15M | 1.4% | +77,000+135.1% | Added | History |
| OMDAOmada Health, Inc. | COM | 390,600 | $7.15M | 1.4% | +390,600 | New | History |
| BEAMBeam Therapeutics Inc. | COM | 409,400 | $6.96M | 1.4% | −300,117−42.3% | Reduced | History |
| HUMHumana Inc | Stock | 27,600 | $6.75M | 1.4% | −53,400−65.9% | Reduced | History |
| CATXPerspective Therapeutics, Inc. | COM NEW | 1,858,596 | $6.39M | 1.3% | −338,674−15.4% | Reduced | History |
| OGNOrganon & Co. | Stock | 640,000 | $6.20M | 1.2% | +105,000+19.6% | Added | History |
| BBIOBridgeBio Pharma, Inc. | COM | 140,000 | $6.05M | 1.2% | +65,000+86.7% | Added | History |
| INSMINSMED Inc | COM PAR $.01 | 59,000 | $5.94M | 1.2% | −48,000−44.9% | Reduced | History |
| MDGLMadrigal Pharmaceuticals, Inc. | COM | 19,000 | $5.75M | 1.2% | +19,000 | New | History |
| RAREUltragenyx Pharmaceutical Inc. | COM | 154,000 | $5.60M | 1.1% | −168,100−52.2% | Reduced | History |
| CNTXContext Therapeutics Inc. | COM | 7,477,255 | $4.90M | 1.0% | +550.0% | Added | History |
| ORKAOruka Therapeutics, Inc. | COM | 352,124 | $3.95M | 0.8% | 00.0% | Unchanged | History |
| IMUXImmunic, Inc. | COM | 5,615,811 | $3.92M | 0.8% | +1,161,403+26.1% | Added | History |
| ARQTArcutis Biotherapeutics, Inc. | COM | 268,000 | $3.76M | 0.8% | +268,000 | New | History |
| DOCSDoximity, Inc. | CL A | 60,000 | $3.68M | 0.7% | −62,500−51.0% | Reduced | History |
| XENEXenon Pharmaceuticals Inc. | COM | 107,891 | $3.38M | 0.7% | −121,109−52.9% | Reduced | History |
| VRNAVerona Pharma plc | SPONSORED ADS | 33,800 | $3.20M | 0.6% | +33,800 | New | History |
| QUREuniQure N.V. | SHS | 207,000 | $2.89M | 0.6% | −129,200−38.4% | Reduced | History |
| APGEApogee Therapeutics, Inc. | COM | 65,000 | $2.82M | 0.6% | +65,000 | New | History |
| SLNOSoleno Therapeutics Inc | COM | 32,000 | $2.68M | 0.5% | 00.0% | Unchanged | History |
| CAHCardinal Health Inc | Stock | 15,000 | $2.52M | 0.5% | +15,000 | New | History |
| SPRYARS Pharmaceuticals, Inc. | COM | 140,000 | $2.44M | 0.5% | +140,000 | New | History |
| KZRKezar Life Sciences, Inc. | COM | 502,600 | $2.30M | 0.5% | 00.0% | Unchanged | History |
| NTLAIntellia Therapeutics, Inc. | COM | 232,000 | $2.18M | 0.4% | +232,000 | New | History |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 39,000 | $1.84M | 0.4% | +39,000 | New | History |
| ARVNArvinas, Inc. | COM | 243,162 | $1.79M | 0.4% | −170,000−41.1% | Reduced | History |
| SNDXSyndax Pharmaceuticals Inc | COM | 150,000 | $1.40M | 0.3% | −775,000−83.8% | Reduced | History |
| SCYXScynexis Inc | COM NEW | 1,228,910 | $829.3K | 0.2% | 00.0% | Unchanged | History |
| KPTIKaryopharm Therapeutics Inc. | COM NEW | 134,566 | $580.0K | 0.1% | 00.0% | Unchanged | History |
| ALTAltimmune, Inc. | COM NEW | 105,000 | $406.4K | 0.1% | +105,000 | New | History |
| ELVNEnliven Therapeutics, Inc. | COM | 11,300 | $226.7K | <0.1% | 00.0% | Unchanged | History |
| RVPHReviva Pharmaceuticals Holdings, Inc. | COM | 138,000 | $52.6K | <0.1% | 00.0% | Unchanged | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| SNDXSyndax Pharmaceuticals Inc | COM | – | $3.18M |
Sold out since Q1 2025 (25)
Positions held at the end of Q1 2025 that are gone from this filing.
| Security | Class | Shares in Q1 2025 | Value in Q1 2025 | % of portfolio in Q1 2025 | History |
|---|---|---|---|---|---|
| REGNRegeneron Pharmaceuticals, Inc. | COM | 25,400 | $16.1M | 3.3% | History |
| GKOSGLAUKOS Corp | COM | 134,000 | $13.2M | 2.7% | History |
| JAZZJazz Pharmaceuticals plc | SHS USD | 80,000 | $9.93M | 2.0% | History |
| NBIXNeurocrine Biosciences Inc | Stock | 85,700 | $9.48M | 2.0% | History |
| State Street SPDR S&P Biotech ETF78464A870 | ETF | 94,000 | $7.62M | 1.6% | – |
| CNTACentessa Pharmaceuticals plc | SPONSORED ADS | 529,000 | $7.61M | 1.6% | History |
| AVTRAvantor, Inc. | COM | 453,000 | $7.34M | 1.5% | History |
| IDYAIDEAYA Biosciences, Inc. | COM | 445,000 | $7.29M | 1.5% | History |
| JANXJanux Therapeutics, Inc. | COM | 258,000 | $6.97M | 1.4% | History |
| BPMCBlueprint Medicines Corp | COM | 68,500 | $6.06M | 1.3% | History |
| UTHRUnited Therapeutics Corp | COM | 16,800 | $5.18M | 1.1% | History |
| BRKRBruker Corp | COM | 115,000 | $4.80M | 1.0% | History |
| BHVNBiohaven Ltd. | COM | 145,000 | $3.49M | 0.7% | History |
| ACADAcadia Pharmaceuticals Inc | COM | 169,000 | $2.81M | 0.6% | History |
| RPRXRoyalty Pharma plc | SHS CLASS A | 87,000 | $2.71M | 0.6% | History |
| CAPRCapricor Therapeutics, Inc. | COM NEW | 239,000 | $2.27M | 0.5% | History |
| LXEOLexeo Therapeutics, Inc. | COM | 645,000 | $2.24M | 0.5% | History |
| VERAVera Therapeutics, Inc. | CL A | 91,000 | $2.19M | 0.5% | History |
| RGNXREGENXBIO Inc. | COM | 260,000 | $1.86M | 0.4% | History |
| IONSIonis Pharmaceuticals Inc | COM | 60,000 | $1.81M | 0.4% | History |
| MIRMMirum Pharmaceuticals, Inc. | COM | 40,000 | $1.80M | 0.4% | History |
| NAMSNewAmsterdam Pharma Co N.V. | ORDINARY SHARES | 68,000 | $1.39M | 0.3% | History |
| AGLagilon health, inc. | COM | 305,100 | $1.32M | 0.3% | History |
| PCVXVaxcyte, Inc. | COM | 23,000 | $868.5K | 0.2% | History |
| HYPRHyperfine, Inc. | COM CL A | 222,174 | $159.1K | <0.1% | History |